Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Psychosis
100%
Africa
100%
Clinical High Risk for Psychosis (CHR-P)
100%
Kenyan
100%
High Risk
66%
Low Risk
50%
Kenya
33%
Impaired Communication
33%
Risk Factors
16%
Major Depressive Disorder
16%
Psychopathology
16%
Early Intervention
16%
Clinical Characteristics
16%
Regression Analysis
16%
Disability
16%
Risk Prediction
16%
Potential Predictors
16%
Early Prevention
16%
Long Follow-up
16%
Early Recognition
16%
Conversion Rate
16%
Prodromal
16%
Behavioral Symptoms
16%
Psychiatric Comorbidity
16%
Preventive Strategies
16%
Structured Interview
16%
High-risk Youth
16%
Psychosocial Stress
16%
Washington
16%
Depression Diagnosis
16%
At-risk Adolescents
16%
Schizophrenia Risk
16%
Occupational Functioning
16%
Bipolar Disorder Depression
16%
Secondary School Students
16%
Affectivity
16%
Time Conversion
16%
Avolition
16%
Machakos
16%
Psychosis Prodrome
16%
Psychosis Risk Syndrome
16%
Psychotic Symptom Severity
16%
Psychology
Adolescence
100%
Longitudinal Analysis
100%
Schizophrenia
50%
Early Intervention
25%
Attention Deficit Hyperactivity Disorder
25%
Bipolar Disorder
25%
Structured Interview
25%
Multiple Regression Analysis
25%
Secondary School Student
25%
Avolition
25%
Prevention of Disorder
25%
Major Depressive Disorder
25%
Major Depression
25%
Major Depressive Episode
25%
Psychopathology
25%
Psychiatric Comorbidity
25%
Medicine and Dentistry
Adolescence
100%
Psychosis
100%
Longitudinal Study
100%
Schizophrenia
25%
Major Depressive Episode
12%
Early Intervention
12%
Attention Deficit Disorder
12%
Bipolar Disorder
12%
Mental Stress
12%
Prodrome
12%
Comorbidity
12%
Diseases
12%
Neurodevelopmental Disorder
12%
Regression Analysis
12%
Neuroscience
Longitudinal Study
100%
Psychosis
100%
Schizophrenia
25%
Attention Deficit Hyperactivity Disorder
12%
Bipolar Disorder
12%
Major Depressive Disorder
12%
Comorbidity
12%
Risk Factor
12%
Psychopathology
12%
Regression Analysis
12%
Biochemistry, Genetics and Molecular Biology
Adolescence
100%
Mental Stress
25%
Comorbidity
25%